Company / Net Income
Arcutis Biotherapeutics, Inc. Net Income History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$16.1M
FY2025
5-year range
-$311.5M / -$16.1M
FY2021-FY2025
Trend
+88.5%
vs FY2024
Sector context
#68 of 216
Health Care
What the data says
At -$16M, Arcutis Biotherapeutics, Inc.'s net income ranks #68 of 216 in the Health Care sector. Net Income has increased for 3 consecutive years, from -$311M in FY2022 to -$16M in FY2025.
Based on SEC 10-K filings.
-$16M in FY2025.
Improved from -$262M to -$16M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#68 of 216 in Health CareTop 31% of 216This company -$16.1M Sector average $454.1M
▼
-103.6% below sector average
Key checks
Key Insights
- Arcutis Biotherapeutics, Inc.'s net income has grown for 3 consecutive years.
- In FY2025, net income increased 88.5% year-over-year.
- Ranks #68 out of 216 companies in the Health Care sector.
- Lowest net income in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -0.65 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$16.1M | +88.5% |
| FY2024 | -$140.0M | +46.6% |
| FY2023 | -$262.1M | +15.8% |
| FY2022 | -$311.5M | -50.9% |
| FY2021 | -$206.4M | -52.1% |
| FY2020 | -$135.7M | -223.1% |
| FY2019 | -$42.0M | -118.1% |
| FY2018 | -$19.3M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026